For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before the cancer comes back. Researchers at UCLA have found that a blend of a ...
Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
In 2013, a prostate-specific antigen (PSA) blood test revealed that Richard LaFrate's levels had jumped. Previously in a normal range, LaFrate's PSA was now above 6 ng/mL, indicating an elevated ...
Prostate cancer is the second leading cause of cancer-related deaths among American men, claiming almost 35,000 lives annually. Androgens, male sex hormones, fuel the growth of most prostate tumors by ...
Nubeqa plus androgen deprivation therapy displayed positive radiological progression-free survival results in early trial data. Among patients with metastatic hormone-sensitive prostate cancer, the ...
“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...
When researchers at City of Hope Comprehensive Cancer Center in Duarte, California, began studying white button mushrooms, they uncovered something remarkable. These common mushrooms, found in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback